Old drug, new data
Authors:
- I. Nicol FerrierIFI. Nicol Ferrier
- Lindsey J. FerrieLFLindsey J. Ferrie
- Karine A. MacritchieKMKarine A. Macritchie
- 1 July 2006
- journal article
- Published by Cambridge University Press (CUP) in Advances in Psychiatric Treatment
- Vol. 12 (4) , 256-264
Abstract
New data have emerged over the past 10 years regarding the efficacy and mechanisms of action of lithium. This article briefly summarises the evidence for the use of lithium to treat affective disorders and psychosis, reviews its putative anti-suicidal effect, highlights new research on its mechanism of action and provides an update on some important side-effects and consequences of its use.Keywords
This publication has 57 references indexed in Scilit:
- The Syndrome of Irreversible Lithium-Effectuated NeurotoxicityClinical Neuropharmacology, 2005
- Lithium treatment inhibits protein kinase C translocation in rat brain cortexPsychopharmacology, 2001
- Does Lithium Exert an Independent Antisuicidal Effect?Pharmacopsychiatry, 2001
- Drug-Induced Diabetes InsipidusDrug Safety, 1999
- Adaptive changes in the rat dopaminergic transmission following repeated lithium administrationJournal of Neural Transmission, 1996
- GABA receptor alterations after chronic lithium administration. Comparison with carbamazepine and sodium valproateProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1992
- Less frequent lithium administration and lower urine volumeAmerican Journal of Psychiatry, 1991
- Focal segmental glomerulosclerosis in patients receiving lithium carbonateThe American Journal of Medicine, 1988
- Effects of chronic lithium treatment on brain monoamine metabolism and amphetamine-induced locomotor stimulation in ratsJournal of Neural Transmission, 1985
- Monoamine uptake into synaptosomes from various regions of rat brain following lithium administration and withdrawalNeuropharmacology, 1981